CPSC2025-04-10
Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging
Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare, of Bridgewater, New Jersey)
Hazard
The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
Remedy
Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
Sold at
HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.
Affected count
About 14,250
Injuries reported
None reported
Manufactured in
India
Remedy type
Refund
Products
Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
Consumer contact
Kramer Laboratories at 800-824-4894 Monday through Friday 8 a.m. to 5 p.m. ET, e-mail at kramerlabs@emersongroup.com, or online at https://safetussin.com/recall for more information.
Official notice
https://www.cpsc.gov/Recalls/2025/Kramer-Laboratories-Recalls-Safetussin-Max-Strength-Multi-Symptom-Cough-Cold-and-Flu-Blister-Packs-Due-to-Risk-of-Child-Poisoning-Violation-of-Federal-Regulation-for-Child-Resistant-PackagingDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief